Please select the option that best describes you:
Topics:
General Internal Medicine • Rheumatology • Rheumatoid Arthritis • Interstitial lung disease • Pulmonology • Diffuse Parenchymal Lung Disease • Pulmonary
How do you manage pleuroparenchymal fibroelastosis in a patient with seronegative RA that is progressing on Rituxan and DMARD therapy?
Is there a role for antifibrotics in these patients?